However, to fully assess its specificity, future studies should investigate whether C1qtnf6 expression is also elevated in nonmalignant lung diseases, such as COPD or pulmonary fibrosis, to determine its potential diagnostic boundaries. This evidence concerns the gene C1QTNF6 and lung disorder.